January 2025 | Sinfonie will attend Biotech Showcase and the Annual J.P. Morgan Healthcare Conference in San Francisco

We are delighted to share that Sinfonie Life Science Management GmbH will attend two key industry events in San Francisco this January:

 

  • Biotech Showcase 2025 (January 13-15) – a leading conference for biotech innovation, fostering collaborations and partnerships among Biopharma and Investment firms.
  • 43rd Annual J.P. Morgan Healthcare Conference (JPM 2025) (January 13-16) – the largest and most influential healthcare investment symposium, bringing together industry leaders, investors, and innovators across biopharmaceuticals, medical devices, and digital health.

Our Managing Director, Peter Heinrich, will represent Sinfonie at both events. We are eager to reconnect with clients and collaborators, and to engage with new partners interested in business development & licensing, strategic advisory, and M&A opportunities.

November 2024 | Sinfonie is attending BIO-Europe in Stockholm from November 4th-6th

Peter Heinrich, Co-founder and Managing Director at Sinfonie Life Science Management, will be speaking at the 30th Annual BIO-Europe in Stockholm from November 4-6, 2024.
 
BIO-Europe is the leading partnering event for the biotech and life sciences sectors, and this year it will bring together experts to discuss key topics like AI in healthcare, pharmaceutical innovations, big data’s impact on life sciences, and advancements in cell & gene therapy.
 
Sinfonie looks forward to connecting with industry leaders, exploring new innovations, and forming meaningful partnerships.

October 2024 | Sinfonie is attending CPHI in Milan from October 8th-10th

Sinfonie Life Science Management GmbH will be attending CPHI 2024 in Milan, Italy. Martin Pöhlchen, Sinfonie’s Managing Director, will represent our team at this renowned global pharmaceutical exhibition.

 

CPHI 2024 brings together industry leaders from around the world to showcase the latest innovations across the entire pharmaceutical supply chain. This event offers valuable opportunities to connect with key players in the pharma industry, explore groundbreaking technologies, and participate in insightful discussions on trends such as personalized medicine, precision manufacturing, and digital health solutions.

 

We look forward to engaging with thought leaders, partners, and innovators, as Sinfonie continues building strategic relationships across the global pharmaceutical industry.

April 2024 | Sinfonie attends the German Biotech Days and the Swiss Biotech Day

This month, Sinfonie took part in two events awaited by the European biotech sphere: the German Biotech Days and the Swiss Biotech Day. These gatherings serve as pivotal platforms for industry professionals to exchange knowledge, foster collaborations, and explore emerging trends in the biotechnology sector.


The German Biotech Days, held on April 8th–9th, provided a platform for Sinfonie to engage with key players in the German biotech industry, fostering collaborations and exchanging insights on the latest advancements in the field. 


Following this, Sinfonie participated in the Swiss Biotech Day on April 23rd. Amidst discussions on cutting-edge research, financing trends, and regulatory updates, Sinfonie leveraged this opportunity to network with industry peers and explore potential avenues for strategic partnerships.


With a dedicated focus on BD & Licensing, Strategic Advisory, and M&A transactions, Sinfonie’s presence at these events reaffirms its dedication to driving innovation and facilitating impactful partnerships within the life science community.

March 2024 | Sinfonie will attend BIO-Europe Spring on March 18th–20th in Barcelona

Our Managing Director, Martin Pöhlchen, will be looking to engage with previous and prospective clients, explore collaborative opportunities, and share insights with industry leaders at the upcoming BIO-Europe Spring. 

January 2024 | Sinfonie will attend Biotech Showcase on January 8–10 in San Francisco

Sinfonie’s Managing Director Peter Heinrich will attend Biotech Showcase this January. Sinfonie looks forward to catching up with previous clients and collaborators, and to making new connections with Biotech, Pharma and Digital Health companies interested in BD & Licensing, Strategic Advisory and M&A transactions.

November 2023 | Sinfonie will attend BIO-Europe on November 6-8 in Munich

Sinfonie’s Managing Director Martin Pöhlchen will attend BIO-Europe this November, a short way from Sinfonie’s headquarters in Munich. Sinfonie looks forward to connecting with Biotech and Pharma companies to promote existing and prospective projects in BD & Licensing, Strategic Advisory and M&A transactions.

August 2023 | Sinfonie is glad to share that it acted as a strategic co-advisor for PPF Biotech and SCTbio in the transaction with eureKING

PPF to participate in formation of leading new European biotech manufacturer

Sinfonie Life Science Management and Alira Health acted as strategic advisors to SCTbio and PPF Biotech Group in this transaction with eureKing, the first European healthcare SPAC dedicated to biomanufacturing. Please find out more by downloading our press statement below.

July 2023 | We are happy to share that Dr. Liliana Garcia Mondragon has joined Sinfonie as a consultant.

Welcome to the team, Liliana!

January 2023 | We are happy to announce that Dr. Dorothee Pöhlchen has joined Sinfonie as a consultant.

Welcome to the team, Dorothee!